The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 355:1372-1374 September 28, 2006 Number 13
NextNext

Diabetes Cure — Is the Glass Half Full?
Jonathan S. Bromberg, M.D., Ph.D., and Derek LeRoith, M.D., Ph.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
 by Shapiro, A.M. J.
-PubMed Citation
Nearly 80 years after the first clinical use of insulin, many important advances in the treatment of type 1 diabetes mellitus continue to be made. In this issue of the Journal, Shapiro et al.1 report on a multinational, prospective trial to disseminate the complicated knowledge and techniques required to prepare and transplant human islets and to evaluate the ability to provide a durable cure for a highly selected group of patients with type 1 diabetes.

It is important to realize how far this field has come in the past few years (Figure 1). Before 2000, the preceding two . . . [Full Text of this Article]


Source Information

From the Mount Sinai School of Medicine, New York.


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.